Sofinnova Venture Partners X, L.P.
Insider CIK 1680200 · BOLT 10% owner · INZY 10% owner · AKUS 10% owner · AVTE 10% owner · VERA 10% owner · CINC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 9,803 | — | $0 | 19,608 | SEC↗ |
| CINC CinCor Pharma, Inc. | D To issuer | 2023-02-24 | 2023-02-27 | 19,608 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 6,073,949 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-06 | 2023-02-08 | 285,714 | $7.00 | $2.00M | 3,467,156 | SEC↗ |
| CINC CinCor Pharma, Inc. | S Sale | 2022-11-28 | 2023-02-27 | 6,000 | $14.32 | $85.9K | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-11 | 2022-08-15 | 500,000 | $30.00 | $15.00M | 6,073,949 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2022-02-10 | 2022-02-14 | 266,666 | $15.00 | $4.00M | 3,181,442 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 13,571,428 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 4,275,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 5,248,949 | — | $0 | 5,248,949 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 325,000 | $16.00 | $5.20M | 5,573,949 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 10,565,238 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | P Buy | 2021-07-02 | 2021-07-06 | 357,142 | $14.00 | $5.00M | 3,758,686 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 3,401,544 | — | $0 | 3,401,544 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 727,272 | $11.00 | $8.00M | 2,914,776 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 2,304,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 450,000 | $20.00 | $9.00M | 2,754,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 1,104,209 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 11,888,112 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,590,808 | — | $0 | 1,590,808 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 437,500 | $16.00 | $7.00M | 2,028,308 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 12,643,557 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 18,044,028 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 58,823 | $17.00 | $1000.0K | 1,515,073 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 599,988 | — | $0 | 1,456,250 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 856,262 | — | $0 | 856,262 | SEC↗ |